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Background: This paper proposes a novel model for homeopathic remedy action on living systems. Research
indicates that homeopathic remedies (a) contain measurable source and silica nanoparticles heterogeneously
dispersed in colloidal solution; (b) act by modulating biological function of the allostatic stress response network (c)
evoke biphasic actions on living systems via organism-dependent adaptive and endogenously amplified effects; (d)
improve systemic resilience.
Discussion: The proposed active components of homeopathic remedies are nanoparticles of source substance in
water-based colloidal solution, not bulk-form drugs. Nanoparticles have unique biological and physico-chemical
properties, including increased catalytic reactivity, protein and DNA adsorption, bioavailability, dose-sparing,
electromagnetic, and quantum effects different from bulk-form materials. Trituration and/or liquid succussions
during classical remedy preparation create “top-down” nanostructures. Plants can biosynthesize remedy-templated
silica nanostructures. Nanoparticles stimulate hormesis, a beneficial low-dose adaptive response. Homeopathic
remedies prescribed in low doses spaced intermittently over time act as biological signals that stimulate the
organism’s allostatic biological stress response network, evoking nonlinear modulatory, self-organizing change.
Potential mechanisms include time-dependent sensitization (TDS), a type of adaptive plasticity/metaplasticity
involving progressive amplification of host responses, which reverse direction and oscillate at physiological limits.
To mobilize hormesis and TDS, the remedy must be appraised as a salient, but low level, novel threat, stressor, or
homeostatic disruption for the whole organism. Silica nanoparticles adsorb remedy source and amplify effects.
Properly-timed remedy dosing elicits disease-primed compensatory reversal in direction of maladaptive dynamics of
the allostatic network, thus promoting resilience and recovery from disease.
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Summary: Homeopathic remedies are proposed as source nanoparticles that mobilize hormesis and
time-dependent sensitization via non-pharmacological effects on specific biological adaptive and amplification
mechanisms. The nanoparticle nature of remedies would distinguish them from conventional bulk drugs in
structure, morphology, and functional properties. Outcomes would depend upon the ability of the organism to
respond to the remedy as a novel stressor or heterotypic biological threat, initiating reversals of cumulative,
cross-adapted biological maladaptations underlying disease in the allostatic stress response network. Systemic
resilience would improve. This model provides a foundation for theory-driven research on the role of nanomaterials
in living systems, mechanisms of homeopathic remedy actions and translational uses in nanomedicine.
Keywords: Homeopathy, Nanoparticles, Silica, Epitaxy, Hormesis, Cross adaptation, Time dependent sensitization,
Metaplasticity, Allostasis, Complex adaptive system, Stress response network, Resilience, NanomedicineBackground
The purpose of this paper is to propose a model that
explains how homeopathic remedies act on living sys-
tems (Figure 1). Basic science research suggests that
classically-prepared homeopathic remedies (A) contain
measurable source nanoparticles (NPs) and/or silica
nanoparticles with adsorbed source materials [1-4]
which are heterogeneously dispersed in colloidal solu-
tion; (B) act by modulating biological function of the
allostatic stress response network [5,6], including cyto-
kines, oxidative stress and heat shock proteins [7,8], as
well as immune, endocrine, metabolic, autonomic and
central nervous system functions [9,10]; (C) evoke bi-
phasic actions on the adaptive plasticity of living sys-
tems [11-15] via organism-dependent, endogenously
amplified, rather than agent-dependent pharmaco-
logical, effects [16]. The effects of homeopathic remedy
nanoparticles involve state- and time-dependentFigure 1 Nano particle model for homeopathic remedy action: horme
of the nonlinear stress response mediator network. Global and local he
system in response to the individualized remedy serving as personalized ho
stimulating self-amplified, bidirectional adaptive change (see text).adaptive changes [7,8,17-20] within the complex adap-
tive organism [19-22]. The main clinical outcome is
(D) improvement in systemic resilience to future envir-
onmental stressors and recovery back to normal
healthy homeostatic functioning [23]. Disease resolves
as an indirect result of changing the system dynamics
that had supported its original emergence [21,22], ra-
ther than as a direct result of suppressing end organ
symptoms.
Other investigators have proposed a variety of theories
for homeopathic remedy effects, e.g., persistent memory
of unique water structures, water-ethanol clusters, epi-
taxy, and nanobubbles [24-32], glass-derived silica crys-
tals and structures [4], electromagnetic activities [33],
biological signaling [9], quantum macro entanglement
[34,35], nonlinear dynamics of complex systems
[13,19,20], stressor effects and hormesis [36-38]. The
current nanoparticle-cross adaptation-sensitization modelsis, allostatic cross-adaptation, and time-dependent sensitization
aling occur across the person as a self-organized complex adaptive
rmetic stressor, i.e., holistic nanomedicine: an exogenous nanoparticle
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and empirical findings from this previous body of work,
while offering an integrated, comprehensive synthesis for
systematic testing [39].
Homeopathy is an over 200-year-old system of com-
plementary and alternative medicine (CAM) developed
by the German physician Samuel Hahnemann, MD. The
field has a well-articulated practice theory [40], extensive
case report-based clinical literature [41], high levels of
patient satisfaction [42,43], and a growing modern re-
search base [44,45]. Nonetheless, homeopathy has
engendered some of the most intense skepticism within
CAM, largely over the nature of its medicines (“remedies”).
The classical process of manufacturing homeopathic medi-
cines involves trituration in lactose and/or serial dilution
in ethanol-water solutions and succussion (vigorous
repeated cycles of shaking via hand or standardized mech-
anical arm pounding on a hard surface) in glass vials con-
taining ethanol-water solutions [40]. Common dilution
factors are 1 part source to 9 parts diluent (1/10, decimal,
D or X potencies) and 1 part source to 99 parts diluent
(1/100, centesimal or C potencies). Original bulk-form
source materials are typically plant, mineral, or animal in
nature.
Once dilution and trituration steps in lactose and/or
succussions in liquid solvents begin, any low potency
homeopathic remedy prepared above mother tinctures,
i.e., 1X to 23X or 1C to 11C, should theoretically still
contain bulk-form molecules of source material as well
as source nanoparticles [3,46]. In theory, repeated dilu-
tion steps leave progressively fewer and fewer molecules
of bulk-form source material in a true solution, until
eventually none should persist in solution diluted past
Avogadro’s number (6 x 1023), i.e., potencies higher than
24X or 12C. Ordinary clinical chemical assays can at
best find relatively low numbers of bulk-form source
molecules, for remedies at low potencies and none at
higher potencies. As a result, conventional medical
scientists and chemists reject the plausibility of homeop-
athy because of the presumptive lack of sufficient bulk-
form source material to exert a “usual” pharmacological
dose–response effect. In typical clinical pharmacology,
lower bulk-form “doses” should exert lesser effects, until
there are no biological effects at all.
These points are seemingly valid, if the underlying
assumptions are valid – i.e., that homeopathic medicines
are ordinary, dissolved and diluted bulk-form chemical
drugs in true solution that could only act pharmaco-
logically [47] with linear dose–response relationships.
However, the trituration and succussion procedures in
classical homeopathic remedy preparation may actually
be crude manual methods that generate “top down”
nanoparticles of source material. Nanoparticles range in
size from 1 nanometer (nm) on a side up to 1000 nm ormore, though much nanoscience research focuses on
special acquired properties of small nanoparticles below
100 nm [48]. Trituration with mortar and pestle is a
manual method for mechanical grinding or milling,
similar to ball milling used in modern nanotechnology
[49,50]. Like modern nanotechnology methods of micro-
fluidization [51,52], sonication [53,54], and vortexing
[55], manual succussions introduce intense turbulence,
particle collisions, and shear forces into solution that
break off smaller and smaller particles of remedy source
material as well as silica from the walls of the glass con-
tainers or vials [1]. The combined impact of these mech-
anical nanosizing procedures [54] would be to modify
the properties of the remedy [26,30,32], generating rem-
edy source nanoparticles [2,3], as well as silica crystals
and amorphous nanoparticles [3,4,32].
Persistent remedy source nanoparticles have been
demonstrated with high resolution types of electron mi-
croscopy in metal and plant homeopathic remedies pre-
pared both below and above Avogadro’s number [2,3].
Studies also report finding measurable amounts of nano-
silica and its precursors in glassware-prepared remedies
and other medicines [3,4,32,56]. The types of glassware
[56] (or polymer containers [1]), pH, temperature,
amounts of agitation, and the ratio of ethanol to water
solvent [57,58] can further modify the specific sizes and
properties of the resultant nanoparticles. Nanoparticles
are different from bulk-form materials as a function of
their small size, including acquired adsorptive [56,59],
electromagnetic, optical, thermal, and quantum proper-
ties [33,48,60,61].
With their highly reactive and catalytic surfaces [48],
NPs aggregate through self-assembly, and readily adsorb
other nanoparticles and organic materials onto their sur-
faces, e.g., DNA, proteins, plant extracts or lactose
[48,60,62-68]. In addition to mechanical attrition meth-
ods, multiple studies have demonstrated that plant
mother tinctures can biosynthesize metal (silver or gold)
or silica (silicon dioxide) nanoparticles and structures
via natural phytochemical reactions in vitro [64,69-72].
When plant herbal tinctures are used for biochemical
synthesis of silver or gold metal nanoparticles from
metal salt solutions, evidence indicates that the herb
adsorbs onto the surfaces and modifies the sizes and
properties of the resultant metal nanoparticles during
this “green” manufacturing process [64,69,73]. The metal
NPs then can convey plant-modified specific biological
effects [64]. Such nanoparticles could augment and amp-
lify the more direct, bulk herb-like properties for very
low potency remedies made from ethanolic plant mother
tinctures [46].
At higher liquid potencies, silica from the glass con-
tainer walls released during succussions appears to be an
important contributor to the generation of active
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also show that nanosilica can self-assemble into
3-dimensional structures that can withstand drying, using
DNA, proteins, or living cells as biological templates
(a type of epitaxy) [71,72,75-78]. The interaction and ad-
sorption of specific remedy source with lactose and/or sil-
ica in the lowest homeopathic potencies such as 1C or 1X
and the next few very low potencies in glass vials
containing ethanol-water solutions would create remedy-
specific lactose- [79] and/or silica-adsorbed “nanoseeds”
for generating subsequent potencies [3,64].
Once formed at lower potencies, remedy NPs and
remedy source-modified nanosilica [64,67,78] could be
capable of seeding regrowth or self-assembly of pre-
formed silica nanostructures at higher potencies
[4,32,71,80]. Nanotechnologists regularly use silica in
bottom up self assembly of specific nanostructures based
on DNA, proteins, or other materials as epitaxial struc-
tural templates [67,77]. Any involvement of silica [3] or
other nanostructures [32] would occur in addition to the
demonstrated physical transfer of detectable remedy
source nanoparticles themselves during the serial dilu-
tions into higher potencies [2]. Nanosilica would serve
as a non-specific biological amplifier [81,82], if present
[1], as well as a vehicle for additional remedy-specific
structural and/or electromagnetic information.
For instance, one type of amorphous nanosilica can re-
tain memory of an electric- or magnetic-field induced
orientation [83]. Previous studies have shown that some
homeopathically-prepared materials can emit detectable
electromagnetic signals [33]. Such signals could, along
with the adsorbed and perhaps encapsulated remedy
nanomaterial structures [65] and epitaxial processes
[3,24,64,71], thereby convey remedy-specific information
in these multiple ways. The information could derive
from lasting alterations in the electrical conductivity of
nanosilica and other nanostructures. The process might
take advantage of silicon’s semiconductor capabilities
when “doped” with very small quantities of some inor-
ganic or organic materials, i.e., from remedy source NPs
in liquid potencies. However, since homeopathic remed-
ies are often dried onto lactose pellets for storage and
convenient transport, any model for homeopathy must
also accommodate the need to retain the remedy-
specific signal while dried and restore it upon clinical
administration. Silica and protein nanostructures can
survive drying [66,77]. Lactose can absorb intact nano-
particles sprayed onto its surfaces [66].
Detection and study of these particles and proposed
nanostructures present scientific challenges. Ordinary
chemical assays and light microscopy cannot detect the
nanoparticles, especially at higher potencies [84,85]. Cer-
tain types of spectroscopy, e.g., Raman [24], but not always
others, e.g., NMR [32,86], can indirectly detect theirpresence in solution. Various physico-chemical methods
can find indirect evidence from heat or light release
by disrupting the dynamic structures that nanoparticles
form in the solvent. High resolution imaging techniques
[84,87,88], including atomic force microscopy, scanning
electron microscopy, or transmission electron micros-
copy, can directly provide images of the actual presence
of identifiable source nanoparticles in a given remedy
[2,3,69]. Technological advances for characterizing single
nanoparticles may also facilitate this type of research
[88,89]. With their increased bioavailability and reactivity,
nanoparticles lower the doses of a drug, herb, nutriceuti-
cal, or antigen needed to produce clinical effects in med-
ical applications, by orders of magnitude [63,68,90,91].
Discussion
Overview of the model
Three assumptions frame the discussion, and four prin-
ciples provide the theoretical basis for this model.
The assumptions from the mainstream physiological
literature are:
(1) Human beings, animals, and plants are complex
adaptive systems or interconnected self-organizing
networks [23,92-94];
(2) The allostatic stress response network of nervous,
endocrine, immune, and metabolic pathways within
the larger network of the organism is a hub that
interacts with and adapts to environmental stressors
[5,95,96]. Such stressors are any type of exogenous
(or endogenous) stimulus that can disrupt
homeostatic balance in the human being as an
organism [5,94].
(3) Progressive allostatic overload of the adaptive
capacity of the organism by higher intensity
stressors leads over time to changes in functional
set points and dynamic attractor patterns [10] that
underlie the emergence of chronic disease. Disease
manifests as unique complex, nonlinear, dynamical
patterns of maladaptive function, determined by
genetic, epigenetic, and lifestyle factors [5,95].
There are four principles of the nanoparticle-allostatic
cross-adaptation-sensitization (NPCAS) model that ex-
plain homeopathic remedy action:
(A) Homeopathic remedies are highly reactive source
and/or remedy-modified silica (or polymer)
nanoparticles, not bulk-form drugs [2,3];
(B) Remedy nanoparticles stimulate a complex adaptive
response in the organism that begins in the
allostatic stress response network, with cascading
indirect consequences over time across the entire
self-organizing organism. The homeopathic
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nanoparticles [16] serve as low level, but highly
salient novel stressors, i.e., specific biological signals
for the overall organism [9];
(C) The adaptive plasticity processes that underlie the
direction and magnitude of remedy effects on living
systems involve nonlinear physiological phenomena
such as hormesis, cross-adaptation, time-dependent
sensitization and cross-sensitization/oscillation. As
a low intensity stressor, remedy nanoparticles
stimulate changes in the opposite direction to those
of the higher intensity stressors that fostered the
original development of disease [16,97,98]. The
disease-related maladaptations prime the system
[10,39]. Then the correct remedy in low dose elicits
reversal of direction of the maladapted responses.
(D) The adaptive changes that the remedy evokes
ultimately strengthen systemic resilience. The
successfully treated individual can resist and
rebound from subsequent challenges from higher
intensity homeostatic disruptors of the organism as
a complex network, at global and local levels of
organizational scale [22].
In the context of medicine [99-101] and complemen-
tary and alternative medicine (CAM) [13,19-22],
researchers have previously detailed the evidence that
living organisms are complex adaptive systems (CAS) or
networks of interconnected, interregulated components.
Other investigators have extensively addressed the role
of the allostatic stress response network within the or-
ganism in adaptation, maladaptation, and the develop-
ment of disease [5,94,95]. This paper will build upon
concepts and findings from the CAS and allostasis-
adaptation literatures integrating the research on
homeopathic remedies and nanoparticle properties with
physiological findings on the processes of adaptation and
response amplification. The current model will facilitate
development of specific, testable hypotheses for theory-
driven homeopathic remedy research [39].
Literature informing model development
Principle (A). Homeopathic remedies are highly
reactive source and/or remedy-modified silica (or
polymer) nanoparticles, not bulk-form drugs [2,3];
The active components of homeopathic remedies, other
than plant mother tinctures, are nanoparticles of the
source substance [2] and/or source substance adsorbed
to the surface of or entrapped within silica or polymer
vehicle nanoparticles [1,3,62-65] in ethanol-water col-
loidal solution. At higher potencies, bottom-up nanosilica
self-assembly and epitaxial templates from remedy source
nano-forms encountered during earlier preparation atlower potencies could also acquire, retain, and convey
remedy-specific information [3,4,78]. Other than in plant
mother tincture concentrates [46], remedies are not purely
bulk-form material drugs. Trituration of insoluble bulk
form materials, which is mechanical grinding in lactose,
would generate source material and lactose amorphous
nanoparticles and nanocrystals [49,79]. With or without
source bulk-form material trituration, repeated succus-
sions in ethanol-water solutions would generate not only
remedy source nanoparticles [2,3], but also silica (or syn-
thetic polymer) nanoparticles and nanostructures from
the walls of the glass (or synthetic polymer) containers in
which the succussion occurs [3,4,56,64].
Nanotechnology research suggests that variations in a
number of different manufacturing parameters, e.g.,
glassware, solvent, pH, temperature, type of container,
grinding methods, force and number of cycles of agita-
tion of fluids, will affect the sizes, shapes, and properties
of resultant nanoparticles [57,58,102]. For instance,
smaller nanoparticles, e.g., 16 nm nanosilica, are gener-
ally more toxic to healthy cells than larger nanoparticles
of the “same” material [103-106]. However, compared
with smaller NP sizes (e.g., 20 nm), larger size nanoparti-
cles (e.g., 80 nm) of the “same” calcium phosphate
source material induce apoptosis more effectively in
osteosarcoma cancer cells [107]. Notably, the homeo-
pathic remedy Calcarea Phosphoricum in low potencies
has long been part of the Banerji treatment protocols for
osteosarcoma and other cancers in India [108].
A recent empirical breakthrough in understanding the
basic nature of homeopathic remedies demonstrated
that even commercial metal remedies (source materials:
gold, copper, tin, zinc, silver, and platinum) triturated,
diluted and hand-succussed to 30C or 200C potencies
(both above Avogadro’s number) retain nanoparticles of
their source material [2]. Some have criticized the
Chikramane et al. paper for using sample preparation
methods that failed to detect size differences of nanoparti-
cles at different potencies [109]. Nonetheless, the overlap
of classical homeopathic manufacturing and mechanical
top-down nanoparticle nanotechnology manufacturing
methods and findings from other basic science laborator-
ies converge with similar findings [3,24,64].
For instance, Upadhyay and Nayak [3] used electron mi-
croscopy to demonstrate nanoparticles and nanocrystals
in three different homeopathically-prepared plant remed-
ies at 1C through 15C potencies. The latter researchers
also measured greater amounts of silicon in succussed
than in unsuccussed remedies and water controls made in
glass vials. Glass-vial succussed remedies exhibited greater
silicon contents than plastic-vial succussed remedies [3], a
finding consistent with previous studies [1,4,32,74].
Das et al. [64] recently reported using four different
homeopathic plant mother tinctures to biosynthesize
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logical effects differed as a function of the specific plant
used in their manufacturing. The data imply that inter-
action of metal nanoparticles with a bioactive material in
solution can acquire unique properties as a result. Plant
extracts can also induce formation of colloidal silica
structures (cf. [71]). Such nanostructures could undergo
the same types of remedy source adsorption and size
modifications from biochemical interactions with spe-
cific plant or animal source materials, as now documen-
ted for biosynthesized silver NPs.
In an earlier paper, Rao et al. [24] suggested that the
commercial homeopathic remedies they studied con-
tained nanobubbles of oxygen, nitrogen, carbon dioxide,
and possibly remedy source material, generated from the
succussion component of homeopathic remedy prepar-
ation. They also proposed epitaxy (transfer of structural
but not molecular information) as another mechanism
by which specific remedy materials could transfer infor-
mation to water structures in the ethanol-water solution
[24]. Thus, both adsorbed remedy source nanoparticles
and specific epitaxial information transferral to silica
nanostructures [3] are viable hypotheses consistent with
the large literature demonstrating individualized bio-
logical and physical chemistry specificity of different
homeopathic remedies.
These data contribute to better understanding of
reports from two other laboratories studying homeo-
pathic remedies. For example, Elia et al. [26,28] found
that extreme changes in pH, e.g., strong alkaline pH,
cause homeopathic remedy verums to release measurably
excess heat and exhibit higher electrical conductivity
compared with control solvents. They suggested that the
heat release was energy from disruption of ordered struc-
tures in the remedy solutions that was not present in
plain solvents.
Although Elia interpreted their findings in terms of
changes in water structure [26,28], their data are also
consistent with a nanomaterial model. Since several
studies have shown that succussion in glass vials releases
measurable amounts of silica or its precursors [3,4,56],
alkaline pH fosters formation of silica [110], and silica
nanofluids exhibit increased electrical conductivity when
temperature rises [111], the presence of nanoparticles
could account for the increased heat release and elec-
trical conductivity.
In addition, Elia et al. [26] reported that the amount of
heat release and electrical conductivity increased when
their remedy solutions were tested using extreme pH
changes after storage in small volumes for extended periods
of time at room temperature. Such findings are consistent
with the strong thermodynamic tendency of smaller nano-
particles of remedy source and/or silica in liquid sols to ag-
gregate spontaneously and/or self-assemble back intolarger crystalline structures, e.g., via Ostwald ripening,
unless specifically treated to prevent this phenomenon
[112-115]. In nanoscience, the material composition may
not change, but the structural organization and proper-
ties can.
Furthermore, Rey [30] found that, under extreme
in vitro external treatments with low temperatures fol-
lowed by x-ray and gradual rewarming procedures,
higher potency homeopathic remedies released measur-
ably more light energy than did the control solutions.
Rey also noted that two remedies differed from one an-
other in thermo luminescence patterns, but retained the
“fingerprint” properties of the original source substance,
even without the detectable presence of the bulk-form
source material in solution. Although Rey discussed his
data in terms of the “memory of water” models, the lat-
ter findings are consistent with the persistent presence
of identifiable remedy source nanoparticles in the verum
test solutions [2] and/or residual specific remedy source
material and information adsorbed and templated onto
silica nanoparticles and silica nanocrystals [1,3,32,64,69].
On the one hand, silica NPs alone could not explain
Rey’s ability to use thermo luminescence for distinguish-
ing different homeopathic source materials from one an-
other at lower or higher potencies. Other laboratories
have also been able to distinguish one specific higher po-
tency remedy from one another and from succussed
solvent controls using Raman and UV–vis spectroscopic
methods [24,116], as well as less well-known technolo-
gies [117,118]. In contrast, NMR spectroscopy and infra-
red spectroscopy on different remedies have yielded
both positive [32,119] and negative results [86] distin-
guishing specific remedy solutions from controls. On the
other hand, persistent remedy source nanoparticles and
remedy-modified silica nanostructures could provide an
alternative explanation of Rey’s findings of source-
specific information. It is a step forward to recognize that
the remedy source information would be present starting
in very low potencies not only as bulk-form material, but
also as source nanomaterial, while serial dilutions and
succussions proceed toward higher potencies. Even if the
bulk-form materials might be progressively diluted out of
higher potencies, the evidence indicates that the remedy
nano-forms and/or their information persist [2,3,9].
Recent homeopathic research contributes to insights
about minimally necessary factors to make biologically
active remedies. For example, trituration of Arsenicum
Album, followed by dilution without succussion up to a
modified 200C, could still generate biologically active
medicine [120]. However, dilution without prior tritur-
ation or subsequent succussions of cytokines, produced
much less biological activity than succussed forms of the
“same” agent [121]. These findings suggest that either
trituration or succussion is minimally essential for an
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mechanically generate nanoparticles [51].
Optimally, however, as Hahnemann reported in com-
bining trituration and succussion to prepare homeo-
pathic remedies [40], nanotechnologists have also found
that combining mechanical wet grinding with sonication
(agitation in liquid solvent) is more effective than either
method alone for forming, de-aggregating, and dispersing
nanomaterials [54]. Increased dynamic solute aggregation
can occur in aqueous solutions prepared with more ver-
sus less dilution, that is, lower initial solute concentra-
tions [122]. Thus, the cumulative shear forces and
greater de-aggregation from the additional succussions
done while making increasingly higher potencies might
translate into smaller sized remedy nanostructures.
Variability in nanoparticle sizes, shapes, and associated
properties [103,104] would contribute to the known vari-
ability in clinical responses to a specific homeopathic rem-
edy dose. It also explains some of the reproducibility
challenges that have been identified in the literature
[123,124]. These issues do not negate the validity of hom-
eopathy; rather, they suggest theory-driven directions for
systematic research on the variability in remedy nanoparti-
cles, the potential NP contributions to variability in experi-
mental reproducibility in homeopathy, and new ways to
evaluate and control specific variables involved in manu-
facturing methods [1,2] and safety assessments [45,125].
Given the growing body of empirical evidence about
the nanoparticle nature and biological activities of
homeopathic remedies [2-4,7-10,123], it is time toFigure 2 Nonlinear allostatic stress response network: interface with
nanoparticles. This schematic shows some of the physiological componen
nonlinear interrelationships as a network within which they regulate one a
prefrontal cortex, and hippocampus, involved in stress responsivity and rew
function, and motor activity regulate and interact with all of the above com
stress load overwhelms the adaptive capacity of the system and the intera
the dysfunctional dynamics of disease affords the system an opportunity to
biological network [23]. The present model postulates that the correct hom
changes. Used with permission from [5].question the conventional assumption that homeopathic
remedies are “simply” dilutions of ordinary bulk-form
drugs containing “nothing” but unmodified alcohol and
water. The actual evidence suggests that homeopathic
remedies are low doses of different sizes and shapes of
nanoparticles and nanocrystals of their specific remedy
source as well as silica nanostructures with remedy
source material adsorbed to their surfaces [2,3]. In this
context, even higher remedy potencies retain source-
specific structural and electromagnetic “memory” of in-
formation within (i) the nanoremedy NPs and (ii) nanosi-
lica structures [64,83] that initially would self-assemble
in “bottom-up” aggregates [67,76,77,126,127], around the
remedy source materials as structural (epitaxial) tem-
plates in solution [122]. Thus, as an alternative to the
“memory of water” debate surrounding homeopathy, an
empirically-grounded hypothesis would be the “memory
of source and source-modified silica nanostructures.”
The organism treats many types of exogenous nano-
particles, including nanosilica [81,82,128,129], as threats
to its survival. Local cellular interactions with NPs can
lead to systemic signaling [130]. NPs from a salient
homeopathic remedy in potency could act mainly as a
novel, low level threat or exogenous stressor, signaling
danger that sets adaptive responses into motion within
the physiological and biochemical dynamics of the whole
organism [94,128]. Homeopathic remedies would thus
act more as low level triggers for systemic stress
responses than as pharmacological drugs on specific
local tissue receptors [8,37].environmental stressors, including homeopathic remedy
ts involved in the organism’s response to stress and the complex,
nother. Pathways in the central nervous system, including amygdala,
ard, learning and memory, somatosensory function, emotional
ponents. Disease is an emergent outcome when the cumulative
ctions become persistently dysregulated. Targeted, timed disruption of
recover normal regulatory relationships and interactions across the
eopathic remedy provides such a disruption to initiate adaptive
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administered intermittently over time [40], act as
biological stressors that signal [9] a low intensity novel
“threat” to the allostatic stress response network.
Allostatic stress response network
The immediate interface between the environment and
the organism is the allostatic nonlinear stress response
network (Figure 2). In the context of physiology, a stres-
sor is any type of environmental or exogenous stimulus
or signal that perturbs the system’s homeostasis and sets
compensatory adaptive changes into motion. The range
of stressors can include biological, infectious, chemical,
physical, nutritional, electromagnetic, and/or psycho-
social types, i.e., changes that constitute a perceived
threat to the survival of the organism. A lower intensity
stressor that stimulates adaptive plasticity and regulates
the system bidirectionally to restore homeostasis is act-
ing on endogenous processes of adaptation. Well-chosen
homeopathic remedy nanoparticles (simillimum) act as
deep-acting plasticity-modifying signals in chronic dis-
eases. In nanoparticle form, remedies effect these
changes by modulating genetic pathways as well as the
nonlinear dynamical function of biological defenses in
the organism as a complex system [9,131-133], shifting
from a maladapted attractor pattern to a healthier at-
tractor pattern [10,20,21].
In a complex adaptive system, the allostatic network
initiates plastic and metaplastic adaptations that evolve
over time, preparing the organism to maintain and/or
restore homeostasis more effectively in the future if and
when it next encounters a similar stressor/signal. These
biological signals must be spaced over time to avoid
overwhelming the organism’s compensatory capacity.
McEwen [134] emphasized the primary role of the brain
as one of the controlling hubs in the human being as a
complex organism, intercommunicating with bodily cells
and regulating the rest of the stress response network.
In an intact complex organism, cells would send sig-
nals to the brain via the allostatic network [135,136],
e.g., cytokine activation patterns [137]. Perception and
processing of environmental threats from exogenous
stressors occurs in prefrontal cortex, hippocampus, and
amygdala [6,138]. In this context, the salient remedy sig-
nals those brain regions with a perceived low level threat
to survival of the organism. Consistent with this
conceptualization, a previous homeopathic research
study demonstrated unique prefrontal EEG cordance
reactions to sniffing individualized remedies in human
subjects [139]. However, remedies can also initiate
responses at lower local levels of organizational scale.
Thus, isolated cells as biological systems can detect and
respond to environmental stressors [93,140-142]. How-
ever, in vivo, cells and organism maintain a bidirectional,interactive influence on one another [143]. Local cellular
changes send biological signals to the larger system in
which they are embedded, and vice versa [94,130].
Changes in the function of such a major network
within an organism by necessity induce changes in other
physiological networks with which it interacts. In turn,
changes in bodily networks interact bidirectionally with
the emergent global properties of the organism as a
whole [101,143]. Thus, when remedy nanoparticles sig-
nal a novel environmental threat to the immune system
[10], brain and/or other components of the stress re-
sponse network, their effects are indirect and magnified
over time by the organism [21,23,94].
The nonlinear allostatic stress response network
includes not only the immune system and brain, but also
other interactive, mutually regulatory mediators of adap-
tation: e.g., cortisol, parasympathetic and sympathetic
branches of the autonomic nervous system, metabolic
hormones, and biological mediators such as inflamma-
tory and anti-inflammatory cytokines [5]. In the allostatic
model of disease, the cumulative overwhelming effects of
previous stressors (biological, infectious, physical, elec-
tromagnetic, chemical, nutritional and/or psychosocial)
initiate persistent dysregulations in the biology of the
organism’s stress response network. This allostatic over-
load causes adverse changes in functional set points,
from which the body is unable to recover on its own.
The process creates chronic physiological imbalances
and permissive conditions for cumulative damage that
manifest with symptoms of disease [5,95,144]. These
chronic changes in functional set points would corres-
pond in the terminology of complex adaptive systems to
becoming “stuck” in a more rigid and less adaptive dy-
namical attractor pattern [10,20,23,145].
This aspect of the model has support in the basic sci-
ence research literature on homeopathic remedies. Rem-
edies can mobilize various elements of the allostatic stress
response network in vitro and in vivo. Previous empirical
studies have shown that different homeopathic remedies
modulate components of the allostatic stress response net-
work. These findings include remedy-induced changes in
heat shock proteins [7,17,146], cytokines [147-149], im-
mune [150-153], metabolic [12,131], and nervous system
[154-162] function, as well as gene expression patterns
[9,163,164]. Nanoparticles per se can and do mobilize
components of the allostatic network [165-167]. Because
of the interconnected network nature of the allostatic net-
work, however, in vivo studies, which allow the brain and
body to carry on their usual bidirectional homeostatic
interactions with one another, are most likely to capture
the hypothesized role of the allostatic network in adapta-
tion [96] after remedy administration.
The specific pattern of the biological responses
depends in part upon which components of the stress
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stance, an infectious agent or environmental nanoparti-
cles would likely interact first with elements of the
immune system [165,167], but then the cytokines
released as part of the immune and inflammatory re-
sponse in the allostatic network would modulate brain
function, leading to changes in emotional state, mood
and energy levels [136,170]. In the “other” direction
from above downward in the stress response network,
chronic disturbances in brain function such as sleep
deprivation can mobilize sympathetic nervous system
tone, inflammatory cytokine release, and glucocorticoid
activity [171]. If any function begins to go up or down,
other components of the network will mobilize to regu-
late and modulate the extent of the change.
Possible mechanisms from stress signaling capabilities of
remedy NPs
The proposed endogenous process begins with the
homeopathic remedy nanoparticles serving as novel
stressors that signal a salient, organism-wide threat.
Skeptics might argue that even with the nanoparticle
finding, the quantities are “too low” to make a difference
as direct conventional pharmacological agents acting at
local receptors. However, “low” doses of nanoparticles,
which are inherently highly bioactive and catalytic, can
be very low and still elicit meaningful biological
responses as biological signals for adaptive changes
[7-9,16,131,172,173]. Chikramane et al. [2] found meas-
urable quantities of metal remedy source in the nano-
particles they observed from commercially-prepared,
hand-succussed remedies were in the range of 1 to
4000 picograms/ml (approximately 0.05 to 200 pg in a
one drop liquid dose). For perspective, one picogram
of genetic material from a virus (nanosize 10–150 nm),
depending on the virus, could contain approximately
1,000,000 or more virus particle equivalents [174].
Physiological levels of various hormones are in the
pg/ml range.
How would remedy nanoparticles convey their source-
specific information to the allostatic network of the
organism? Once generated, nanoparticles can signal
specific information about their entry into the organ-
ism via their altered size- and shape-dependent chem-
ical, optical, electromagnetic, magnetic, thermal, and/or
quantum properties [33,48,60-62,175]. Data from the
nanoparticle research literature suggest multiple non-
exclusive options: (i) Remedy nano-forms inherently
lower the necessary dose levels [90] because of their
enhanced bioavailability, intracellular access [90], and
biological signaling effects [130], e.g., for plant and min-
eral source materials; (ii) Silica NPs and crystals act as
cellular stressors [128] and adjuvants, i.e., non-specific
biological amplifiers [81,82], to stimulate immunologicaland/or inflammatory reactivity on their own [130] or to
source-specific NPs or antigen [176]. Remedies modulate
specific genomic expression patterns as well [9,163,164].
In addition, quantum phenomena emerge in extremely
small sized NPs with more atom-like characteristics (e.g.,
<50 nm) [48]. Chikramane et al. [2] reported homeo-
pathic metal remedy NP sizes in the range of 5–10 nm,
with the majority of crystallites below 15 nm in size.
Thus, some remedy source NPs and/or silica nanostruc-
tures templated onto source materials during initial
manufacturing steps might also convey remedy-specific
information into higher potencies via quantum macro
entanglement effects [61] in living cells [177]. Rather
than treat the evidence for quantum phenomena in
homeopathic remedy testing as a curious anomaly [34],
the present model allows the possibility that the quantum
mechanical properties of very small nanoparticles
[61,178] could further explain some data on homeopathic
remedies and variability of experimental reproducibility
with placebo-controlled study designs [34,44].
By whatever mechanism(s), the most immediate locus
of action of the correct homeopathic remedy would be
the allostatic stress response network. The remedy nano-
particles would serve as a significant and salient exogen-
ous danger signal that stresses and thus perturbs the
organism’s physiological and biochemical dynamics
(cf. [179]). The state of the organism at the time of dose
administration is an essential factor in the magnitude
and direction of the effects. If the dynamics are currently
dysfunctional or diseased, the low dose remedy-elicited
perturbation “unsticks” the system [10,20,145]. The dis-
ruption provides the system an opportunity to adapt
[93] – i.e., to readjust its processes [23], engage its plas-
ticity [16,23,180-182], reverse direction, and restore
healthier balance across its global emergent function
and local network components [23,93,181,183]. In the
pharmacology and physiology literatures, this beneficial
adaptive process is termed hormesis.
Principle (C). The mediating processes for remedy
effects are physiological, not pharmacological [184].
They include adaptive plasticity and metaplasticity
[181,185] of the organism to amplify [169] and
modulate the direction of its responses to a salient
homeopathic remedy with the passage of time [23],
as a function of the organism’s past history [186,187].
Hormetic changes
Mattson [188] defines hormesis as follows: “Hormesis is
a term used by toxicologists to refer to a biphasic dose
response to an environmental agent characterized by a
low dose stimulation or beneficial effect and a high dose
inhibitory or toxic effect. In biology and medicine,
hormesis is defined as an adaptive response of cells and
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Hormetic effects are nonlinear and depend on specific
adaptive changes in the organism, not on specific
pharmacological effects of the substance [184]. Nanopar-
ticles can cause hormesis [16].
Of relevance to the low doses used in homeopathic
treatment, the small size and heightened reactivity of
nanoparticles [60] that increase bioactivity and bioavail-
ability of drugs, antioxidants, and herbs [62,63,68] would
downshift the hormetic dose–response range even lower
[39]. As a result, the small quantity of remedy needed to
produce an effect – in nanoparticle form – would fall
into the hormetic range [12], potentially far below the
already low doses at which this phenomenon usually
occurs for bulk-form materials [189,190].
The evolutionary advantage of low dose stimulation
rather than inhibition of function is postulated to be the
survival advantage conferred on the organism [191]. The
compensatory changes in response to the low dose ex-
posure pre-adapt the organism in a manner that will
make it more resistant to a repeat danger from the same
stressor, or a cross-adapted stressor [8], at an even
higher, more toxic or lethal potential dose level [192]. At
the same time, living systems self-regulate within a rela-
tively narrow range of function to maintain homeostasis.
For example, if certain brain neurons of an organism
have a lowered threshold for firing after responding to a
given stimulus, then the next stimulus would raise the
threshold, and vice versa [181]. As a result, low intensity
stimuli can activate, and high intensity stimuli dampen,
responses [181].
Cross-adaptation
Cross-adaptation is a well-documented physiological and
biochemical phenomenon [168,169,182,193,194]. In
cross-adaptation, unrelated types of stressors, e.g.,
hypoxia versus cold temperatures, can affect the same
intermediaries in the biological allostatic network
[7,8,187,193]. That is, although two types of environ-
mental stressors can be quite different in nature, the or-
ganism mobilizes the same set of adaptive changes and
subsequently copes better physiologically with both
stressors [168,182,193,194]. Living systems have a broad,
but nonetheless circumscribed, repertoire of possible
behaviors in response to environmental challenges. Evo-
lutionary efficiency may have left the organism with the
ability to prepare itself against a range of future stressors
by initially adapting to one type of stressor [191].
The direction of changes in cross-adaptation can be
bidirectional. That is, a given environmental stressor can
cause adaptive changes in the organism that make it
more or less fit to resist the adverse effects of a different
type of stressor [181,182,195]. As in hormesis, low inten-
sity stressors often produce adaptive changes in theopposite direction to high intensity stressors of the same
or different type [16,98]. The direction and nature of the
response depends on the initial conditions of the organ-
ism, past history of the organism, the pattern of adaptive
responses that the specific stressor can evoke, and the
capacity for adaptation that the organism can achieve
[169]. Cross-adapted responses involve the same com-
pensatory mechanisms in the body that the individual’s
cumulative past specific stress load has already primed
and modified.
When the salient homeopathic remedy serves as a
low-level novel but cross-adapted stressor, salutary
effects would evolve over time because of pre-existing
adaptations to disease-related stressors that the organ-
ism had already developed. In the current model, the
remedy nanoparticles would mobilize a biological cross-
adaptation response [168,169,182,194] to the net effects
of the original stressors that previously led to the disease
state. The direction of changes to the remedy in the or-
ganism, however, would be opposite to those of the
higher intensity stressors that originally caused disease.
That is, well-matched homeopathic remedy nanoparti-
cles mobilize cross-adaptation within the same allostatic
network components that the individual’s disease had
previously affected.
Thus, a homeopathic clinical profile would need to
match global and local symptom patterns and modalities
of expression for the correct remedy (simillimum). The
simillimum for an individual patient who is made worse
by the approach of a storm or hot temperatures (e.g.,
particular physical generalities or modalities in the
homeopathic clinical literature -[196]), must be a novel
stressor with the ability, at higher doses, to evoke a simi-
lar, specific set of physiological adaptations to dropping
barometric pressures or hot environmental temperatures
[182,194,195]. A remedy whose source material bulk
form has no effect either way on the specific adaptations
[195] needed to restore homeostasis during the approach
of a storm or in hot temperatures would be less likely
salient – i.e., therefore less clinically active – for such an
individual.
The nature of the responses that the correct remedy
can elicit in the organism is similar to the nature of the
dysfunctional responses that the previous stressors
initiated as allostatic maladaptations [95]. As the remedy
nanoparticles were not the original causative agent for
disease, researchers would consider it to be a “heteroty-
pic” hormetic stressor for the organism [8,169]. The
prior experience with stressors involved other types of
higher intensity stressors that can cross-adapt with the
remedy effects on the physiology and biochemistry of
the stress response network [187,197]. In short, a well-
chosen homeopathic remedy can cause the same adapta-
tional symptom pattern as the disease-causing stressors
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i.e., heterotypic or heterologous hormetic stressor
[10,198].
Metaplasticity and time-dependent sensitization
Metaplasticity, i.e., the plasticity of plasticity, involves
activity-dependent cellular and molecular priming
mechanisms that initiate long-lasting changes in the ex-
pression of subsequent neuronal plasticity [181]. This
priming process occurs in neural networks involved in
regulating learning and memory, including addictions
[181], as well as emotion [199], somatosensory percep-
tion [200], and movement [201]. These pathways include
prefrontal cortex, hippocampus and amygdala [199,202].
Changes in neuronal excitatory amino acid receptors
such as N-methyl-D-aspartate (NMDA) receptors are
key participants in metaplastic mechanisms as well as
in neuronal damage after injuries to these brain
regions. Glutamate is an exemplar excitatory amino
acid that affects NMDA receptors. Notably, Jonas’s re-
search team previously demonstrated that low doses of
homeopathically-prepared glutamate can attenuate or
reverse direction of adverse effects from high dose glu-
tamate exposure in neuronal cells [160,203].
One stimulus/stressor initiates the metaplasticity; the
next stimulus/stressor (the same or a cross-adapted
stimulus) elicits plastic responses modified by the history
that the organism had with the original stimulus.Figure 3 Dual possible pathways (stressor and/or pharmacological dr
living systems. Exogenous nanoparticles (from pollution, nanomedicine d
adaptation and/or specific pharmacological agents (drugs, toxins) to activa
although the dose would sometimes be insufficient to act as a specific con
in a homeopathic remedy could act as stressors for the organism (homeos
mainly the stress response network pathway, whereas conventional bulk foPushing the system toward its limits leads to a propen-
sity to reverse direction in encounters with subsequent
stimuli [186]. One example is the Bienenstock-Cooper-
Munro rule for experience-dependent plasticity, in
which low level cortical activity increases, whereas high
level cortical activity decreases, synaptic strength of ac-
tive neuronal connections [181,204]. Metaplastic
changes can occur at stimulus levels below those needed
to elicit observable plastic changes and persist long after
exposure to the original stressor ends. Low level and
high level stressors can initiate metaplastic changes in
opposite directions [98,181].
Time-dependent sensitization (TDS) is a form of
metaplastic adaptation that generates progressive en-
dogenous response amplification with the passage of
time between repeated, intermittent stimuli or stressors.
Homeopathic remedy nanoparticles as stressors for the
cells and overall organism would be capable of initiating
and/or eliciting TDS. As in any type of neuronal plasti-
city phenomenon, the initiation and elicitation steps of
TDS are activity-dependent. After the initiating expos-
ure, the system prepares itself with compensatory
changes that amplify over time – “a sensitized defense
response, enabling it to react faster and/or more
strongly, should it ever reencounter the same or a simi-
lar stimulus” [187]. The novelty of the pulsed or inter-
mittent quality of the dosing regimen for the organism is
essential to set endogenous amplification responses intoug) for exogenous agents, including nanoparticles, for effects on
rugs, or homeopathic remedies) might serve as stressors to trigger
te specific receptors on local tissues, at higher dose levels. However,
ventional pharmacological drug, the low levels of nanoparticles found
tatic disruptors). Therefore, homeopathic remedies would engage
rm drugs affect both pathways (stressor and drug).
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sensitized states [187,205]. In TDS, the initiating and eli-
citing stressors or drugs must also be individually salient
for the organism [97,187,206].
For hormesis [16,38], cross-adaptation, and/or TDS
[98,187] to occur in response to a homeopathic remedy
dose, the remedy must be perceived or experienced as a
salient but low level foreign threat or novel biological
stressor, i.e., a potential disruption of homeostasis for
the organism as a whole. Changes in glucocorticoid hor-
mones and corticoid receptors, major components of
the allostatic stress response network, are a necessary
but not sufficient early condition for the initiation of
TDS [207-209]. For a remedy to be clinically effective,
its salience is not to the end organ local mechanisms of
symptoms (pharmacological), but rather to the inter-
mediary adaptations in the allostatic stress response
network components of the organism (physiological).
The growth in magnitude of the response derives from
TDS-based amplifications in the physiological adapta-
tions of the organism, not directly from the size of the
initiating stimulus or stressor. Figure 3 summarizes the
role of the organism in experiencing nanoparticles as
exogenous stressors and/or pharmacological drugs
(or toxicants).Cross-sensitization
Like cross-adaptation, cross-sensitization of amplified
responses also occurs. Chemically-unrelated agents, e.g.,
stress and amphetamine or cocaine [209], sucrose and
stimulant drugs or alcohol [210,211], formaldehyde and
cocaine [212], stress and morphine [213], stress and di-
azepam [214], can all cross-sensitize with one another.
One agent initiates and a different agent elicits sensitized
responses. Antelman interpreted these ubiquitous cross-
sensitization findings to indicate that the shared feature
of the drugs, food, or environmental stimuli was their
quality as novel and threatening stressors, i.e., individu-
ally salient “danger signals” for the organism, rather than
their pharmacologically specific actions [187]. Given the
interdisciplinary nature of the present model and
discipline-related variations in terminology, the neuro-
science concept of cross-sensitization also overlaps that
of “heterologous priming” a term from a more
immunologically-oriented perspective [10], or “heterol-
ogous post conditioning hormesis,” a term from
pharmacology-toxicology and physiology [7,189].
Repeated intermittent episodes of exposures to the same
or a cross-sensitized stressor can elicit progressively larger
responses with the passage of time in TDS [169,187,206].
However, at metaplastically-primed physiological limits,
sensitized responses will change direction (oscillate) with
each successive dose [97,186,187], thereby potentiallypromoting recovery from disease if chosen for salience and
properly timed [11]. As previously noted, in physiology
[169,181,215] and behavioral sensitization studies of non-
homeopathic stressors and drugs [97,98,216-218], the low
versus high dose and the state of the organism interact to
produce polar opposites in the direction of the response
to the “same” stressor or stimulus.
Together with cross-adaptation, these related phe-
nomena of TDS cross-sensitization and metaplastic os-
cillation would help explain the clinically-reported
ability of a homeopathic remedy to reverse chronic
individualized maladaptive patterns in the organism.
That is, the remedy NPs are not only cross-adapted,
but also cross-sensitized to the overall disease-related
dysfunctional changes that are previously established in
the organism at the moment of remedy administration.
The disease is a sensitized emergent set of previously-
amplified dynamical behaviors (allostatic maladapta-
tions) that the body accumulated in response to past
higher intensity stressors of all types. These cumulative
allostatic disturbances manifest as dysfunctional bio-
logical dynamical patterns, induced while the organism
was trying unsuccessfully to cope with overwhelming
cumulative stress effects of adverse childhood experi-
ences, past life traumas, infections, environmental
chemical pollutants, physical stressors, psychosocial
stressors, poor nutrition, and/or various other epigen-
etic factors [5,95,134].
In the present model, a low dose of the correct rem-
edy nanoparticles would push the overloaded allostatic
network to its metaplastically-primed physiological lim-
its, which might induce a transient worsening of symp-
toms, i.e., homeopathic aggravation, before a reversal
of direction of the sensitized response occurs [219]. A
true aggravation reportedly includes a global sense of
increased well-being, suggesting central nervous system
involvement at the onset of the remedy response,
even though local physical symptoms may temporarily
flare, sometimes in association with an acute onset
infection [220].
Alternatively, the correct remedy NPs could arrive in
the organism at a point when the system dynamics are
already disease-primed to a critical dynamic point or
maximum physiological limit [8,23]. In the latter case,
the reversal in direction from disease toward healing
ensues without transient symptom aggravation. Con-
versely, if the remedy is given to a healthy organism, its
metaplastic effects evolve in the direction of enhancing,
not reversing, disease-related adaptations [11]. This
history- and state-dependent type of variability in re-
sponse direction and amplitude is well-documented in the
physiological literature on adaptation, cross-adaptation,
metaplasticity, and cross-sensitization in complex adaptive
systems [181,182,186,187,195,216].
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the involvement of TDS. Convergent research indicates
that sensitization of the central nervous system path-
ways related to pain is a key mechanism in fibromyalgia
(FM) [221]. In persons with FM [222], we found that
repeated intermittent doses of individualized homeo-
pathic remedies initiate progressively sensitized (ampli-
fied) responses of electroencephalographic alpha activity
[154], with specific unique changes over time in pre-
frontal electrode sites for the responders with both glo-
bal health and local pain improvements [223]. In
persons with a mild form of multiple chemical sensitiv-
ity, an FM-related condition also tied mechanistically to
TDS, repeated intermittent sniffs of an individually-
salient homeopathic remedy can induce short-term
EEG alpha effects that are nonlinear and even oscilla-
tory in directionality [14].
As types of metaplasticity, both hormesis and TDS
mobilize adaptive or compensatory changes in an or-
ganism [23] in response to the appraised threat from
novel or foreign stressors, biological agents, chemicals,
physical stressors, and/or drugs, including nanoparticles
[16]. These organism-based, nonlinear adaptive changes
evolve separately from any direct specific pharmaco-
logical actions on receptors, do not require the contin-
ued presence of the initiating agent, and are thus
pharmacologically “nonspecific” [7,8,187]. Rather, the
organism-based response pattern is specific to the past
history and initial state of the organism, the passage of
time, and the timing of repeat doses [5,16,23,187,191].
Pulsed dosing regimens in modulating cells and
organisms as nonlinear dynamical systems
As in TDS, classical homeopathic practice theory sug-
gests the value of using discrete pulses of a remedy (i.e.,
“nanoparticle”) dosed at very low quantities in a timed
manner as biological signals to initiate healing and
stimulate the self-reorganization of the organism [224].
However, current mainstream studies are still focused on
using nanomedicines in relatively higher amounts, as if
they were conventional drugs to force a direct local ac-
tion, requiring continuous blood levels, rather than
intermittent pulsed dosing. Still, nanoparticles reduce
the total amount of a drug or herb needed to produce a
given effect [63,225].
The distinction for homeopathy is that the low level
nanoparticle exposures occur at discrete points in time,
pulsed doses in the salutary low dose hormetic range.
The therapeutic intervention involves small quantities of
nanoparticles, (a) selected for salience to the individual’s
unique emergent maladaptive pattern, and (b) given in
discrete pulses at widely spaced intervals of time as
organism-specific stressors that evoke an endogenous
cascade of adaptive changes [224]. Without the remedyNPs as a discrete low intensity eliciting stimulus, the
organism’s metaplastic priming would not express itself.
Research on dynamical diseases in complex adaptive
systems has shown that pulsed, properly-timed stimuli
can interrupt the dynamics of a pathophysiological
process such as a seizure [226] or a cardiac arrhythmia
[227] and cause the affected system to revert to normal
function [228]. Once an interconnected part of a com-
plex system or network changes its dynamics, the altera-
tions will then cause additional, albeit indirect, changes
distant in space and time from the site of the original
stimulus [20,23]. Complex networks undergo recurring
mutual interaction patterns (motifs) between global and
local organization and function [93,94,142,143].
The pulsed intervention strategy allows the bodily net-
works to respond to the remedy nanoparticle stimulus,
and gives the system time to incorporate changes that
further inform changes and adaptive responses [21,22].
Similarly, TDS also requires intermittent stimulus dosing
for its initiation and evolution [229], thereby allowing
the system time to complete the endogenous amplified
adaptive changes following each dose [230-232], before
giving the next dose. In sensitization, a drug or bio-
logical substance acts as an environmental or exogenous
stressor to disturb homeostasis and initiate adaptive
responses that amplify with the passage of time, without
the continued presence of the initiating agent [187,233].
The capacity for nonlinear amplification of effects from
an initially small stimulus in a complex living system
such as a human being is well-established [23]. Thus,
the rationale for the pulsed dosing regimen relates to the
role of the correct remedy in stimulating endogenous
adaptive changes to an exogenous stressor, not in its use
as a pharmacological agent.
Principle (D). Successful homeopathic treatment
strengthens systemic resilience.
Resilience in a system permits it to bounce back to
normal function on its own after the impact of a given
environmental stressor or challenge [23]. The success-
fully treated individual can resist and rebound from sub-
sequent challenges from higher intensity homeostatic
disruptors of the organism as a complex network, at glo-
bal and local levels of organizational scale [234].
In complex adaptive systems terms, a resilient system
is able to function well within the fitness landscape or
environment in which it is embedded [235]. Faced with
change, a healthy organism is flexible and able to make
further adaptive changes to bring itself back to homeo-
stasis and normal functionality in the context of the
modified environment [23,236]. Of course, overwhelm-
ing change or a hostile environment might again cause
allostatic overload, adverse shifts in functional setpoints,
Table 1 Parallels between homeopathic and modern scientific research literatures
Homeopathic Literature Relevant Modern Scientific Literature
Disease is the manifestation of “dynamic mistunement”
of the living system (life force) [40]
Disease is the current manifestation of failure to adapt or compensate
for allostatic overload from convergence of biological, chemical,
physical, and psychological stressors on the nonlinear adaptive stress
response network, which is embedded within the larger complex
network of the overall organism [95,144]
Homeopathic remedies are made with trituration
and/or serial dilutions and succussions of source
material, usually in glass containers, which generate
nanoparticles of source and source adsorbed to
silica nanoparticles in colloidal solution [1-3,24,64]
Nanoparticles can initiate hormetic low dose responses in the organism
(adaptive or compensatory changes opposite in direction to the effects of
the agent at higher doses) [16]
Remedies prepared and succussed in polypropylene
or polyethylene vials could also have polymer-derived
nanoparticles, but with different properties from
those made in glass [1].
Nanoparticles have high surface to volume area and quantum-like
properties. They differ from bulk source materials in exhibiting greater
ability to translocate around the body and into cells, as well as increased
catalytic activity, adsorptive capacity, and different electrical, magnetic,
optical, and thermal properties from molecules of the “same” bulk
material [33,48,53,60].
Biological structures, e.g., DNA, proteins, or collagen, adsorbed to exogenous
nanosilica and other specific nanoparticle structures, e.g., calcium phosphate or
gold, serve as epitaxial templates for bottom up self assembly of
new biomaterials [76,239,242]
Higher potencies (more dilution and succussion steps)
have longer lasting effects on living systems [243]
(succussion involves intense mechanical shaking
of the solution by pounding the glass container
against a hard elastic surface)
Succussion, like modern microfluidization techniques [51], introduces
cycles of fluid acceleration and turbulence with repeated changes in the
direction of flow, producing the potential for particle collision and shear
forces to break off smaller and smaller particles. These procedures, while
different from each other and from sonication as a technique for
agitating solutions and producing nanoparticles, share the ability to
create nanobubbles and shear forces. Nanoparticle research suggests that
there are nonlinear relationships between the number of microfluidization
cycles or sonication time and variations in the sizes, morphologies, and
physico-chemical properties of the “same” bulk-form material substance
[52,53,244].
Succussion in glass containers releases variable
amounts of silica as nanoparticles [4]; remedy
samples prepared in glass vs polypropylene
containers differ in physico-chemical properties [1]
Direction of effects of sequential remedy
potencies can be nonlinear (oscillatory) in pattern [12]
Such data suggest the hypothesis that different amounts and forces of
succussion should also generate different sizes, morphologies, and
physico-chemical properties of homeopathic remedy source and
remedy-modified silica nanoparticles [64].
Silica [128,245] and polystyrene [246] nanoparticles are used in
conventional nanomedicine as drug/gene delivery vehicles
Direction of effects of sequential nanoparticle cluster sizes can be
nonlinear (oscillatory) in pattern [48]
Pulsed dosing regimens of low doses
(single or intermittent repetitions of remedy
doses, widely spaced in time) exert persistent
effects on physiology and behavior
[13,14,154,159,243]
Low doses of nanoparticles can serve as highly reactive environmental
stressors, not simply as pharmacological agents [187], for the organism to
initiate allostatic adaptations over time. These endogenous changes
compensate for and protect against other cross-adapted or cross-
sensitized stressors (i.e., the adaptations already in place from the
cumulative effects of disease-causing events on the same components of
the stress response network) [5,95].
Single or intermittent repetitions of low intensity levels of a foreign stressor or
substance initiate a process of progressive endogenous response amplification
over time (TDS, time-dependent sensitization) [98]
At the physiological limits of the system, the direction of sensitized responses
become nonlinear (oscillatory) and reverse direction in pattern [7,180,181,186]
In an intact person, patterning of remedy
responses sometimes includes transient
worsening (aggravations) and, when clinically
successful, follows Hering’s Law of Cure
(center of gravity of disease moves from
top to bottom of organism; from more
important to less important organs; and in
reverse order of occurrence in time) [238]
Central nervous system pathways are a major hub for regulating the
allostatic stress response network of the body, interacting with hubs of
the immune, endocrine, and autonomic nervous system to generate the
overall global and local patterns of responses across the organism to any
type of environmental stressor [6,134].
However, homeopathic remedies can also
exert measurable effects on living cells as
complex adaptive systems or networks
[7-9,12,108,147,173].
However, living cells are also complex adaptive networks unto
themselves. As such, cell systems can self-reorganize their biochemical
functional networks in response to a stressor such as heat shock
without requiring the rest of a larger network or brain [93,142].
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Table 1 Parallels between homeopathic and modern scientific research literatures (Continued)
Overcompensation of hormetic adaptations to a low level stressor
can lead to salutary allostatic effects on the organism or complex
adaptive network [247-249]
Human beings are complex adaptive systems that are self-organized,
with interactive global and local patterns of adaptive behavior that
modify each other’s functional behaviors [21,23,94]
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Because of the interactions and interdependence of
subnetworks within a person’s larger complex network
organization [92,101], positive adaptive changes in the
function of the stress response network would, by neces-
sity, foster an evolving cascade of additional adaptations
and persistent positive changes across the rest of the or-
ganism, i.e., system-wide healing into greater resilience
[21,22,145]. As we have previously proposed [21,22,237],
the self-organized, interconnected network nature of the
person [101] would underlie the clinically-reported pat-
tern of homeopathic healing over time, i.e., from above
downward, from more important to less important
organs, and in reverse order in time of symptom appear-
ance [238]. The pattern of clinical response usually
begins in the brain because of its central role in inter-
preting and coordinating physiological responses of the
body to perceived environmental threats and stressors.
The global sense of well-being and symptom improve-
ments at end organs would occur, but as an indirect and
possibly temporally delayed, outcome of restoring allo-
static network function to normal [136].Summary
In summary, the basic tenets of the model are [39]:
Homeopathic remedies are remedy source nanoparticles
and/or remedy-modified silica NPs that act as environ-
mental stressors to mobilize hormesis and time-
dependent sensitization via non-pharmacological effects
on specific biological adaptive mechanisms. Both top-
down mechanical attrition (trituration milling in lactose;
succussion in glass with ethanol-water diluent) and
plant-tincture biosynthesis methods generate the initial
nanostructures. The nanoparticle nature of remedies dis-
tinguishes them from conventional bulk form drugs in
structure, morphology, and functional properties. Fur-
thermore, remedy source nanoparticles, especially in
interaction with nanosilica, have the capacity to initiate
bottom-up self-assembly of biomimetic nanostructures
using crystalline or biological, e.g., DNA, proteins, col-
lagen, templates [71,76,239]. Like a virus, albeit non-
infectious, the homeopathic remedy thus becomes a
salient low-level danger signal or threat to the survival
of the organism.The outcomes depend upon the ability of the organism
to appraise the original high level stressors that caused
disease and the subsequent low level remedy nanoparticles
as novel and salient foreign stressors. Factors identified as
biological threats will signal the need for time-dependent,
sensitized compensatory adaptations (hormesis) in com-
ponents of the allostatic stress response network.
The cumulative impact of allostatic overload from
multiple different stressors led in the past to a pattern
of specific dysfunctional adaptations in the stress re-
sponse network underlying the emergence of disease
[195,240]. The cross-adapted/cross-sensitized homeo-
pathic remedy nanoparticles take advantage of the
priming effect of the prior high level stressors that ori-
ginally caused the disease [10]. The remedy nanoparti-
cles, as a low level stressor, then elicit reversal of
direction in the pre-established, disease-related mal-
adaptive patterns. The net outcome is improved resili-
ence to stress, with restoration of normal homeostatic
function, resolution of disease, and an emergent sense
of global well-being.
Again, “stress” refers to biological, infectious, chemical,
physical, electromagnetic, nutritional and/or psycho-
logical types of environmental stimuli that the organism
recognizes as a novel threat to its survival, now or in the
future. The high or low intensity of the stressor deter-
mines the direction of the adaptations it initiates
[98,187,216], but it is the encroachment of the stressor
on the organism that mobilizes plastic and metaplastic
changes. In short, perceived or experienced novel threat
is more important than dose level to trigger adaptive
responses. Dose comes into play to modulate the direc-
tion of the responses via priming from past cellular activ-
ity history, e.g., metaplasticity, and current plasticity in
the body’s stress response pathways [181].
Within the organism as a complex adaptive system or
network, causality for these events is indirect rather than
direct, distant in time and space to the original adminis-
tration of the homeopathic dose as a small but salient
stimulus or stressor [241]. The organism carries forward
the work of healing as a nonlinear, amplified dynamical
adaptive response [21-23,145]. It is because of the nature
of classical homeopathic prescribing, i.e., selection of a
single remedy administered intermittently, at widely-
spaced intervals of time in pulsed acute dosing regimens
that the treatment system is safe and beneficial.
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pathic clinical concepts and concepts found in the basic
science literature on nanoparticles, hormesis, time-
dependent sensitization, allostatic adaptation, and com-
plex adaptive systems.
Conclusions
The proposed model suggests that homeopathy is not
only scientifically “plausible,” but also grounded in an ex-
tensive empirical research literature. Homeopathic rem-
edies come into existence and exert their biological
effects mainly as nanostructures. Physiology, not
pharmacology, is the most relevant discipline for study-
ing remedy nanoparticle actions (cf., [184,187]). This
paper insists on logic and rationality, as well as open-
minded thoughtfulness, in evaluating the scientific impli-
cations of a large body of interdisciplinary evidence that
health researchers might not otherwise assemble to
understand homeopathic remedies. As empirical data
arise, it is quite likely that new evidence will lead to mod-
ifications of the present theory; such is the nature of sci-
entific inquiry. Nevertheless, this model provides a
rational starting place for a comprehensive research pro-
gram on homeopathic remedy actions. The resultant
findings on what homeopathic remedies are (highly re-
active nanoparticles) and how they interact with complex
living systems (as pulsed, low level doses of a salient and
novel environmental stressor) could significantly advance
the field as a valuable form of nanomedicine.
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